DOCSLIB.ORG

2021 Anatomic & Clinical Pathology

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
2021 Anatomic & Clinical Pathology BEAUMONT LABORATORY 2021 ANATOMIC & CLINICAL PATHOLOGY Physician Biographies Expertise BEAUMONT LABORATORY • 800-551-0488 BEAUMONT LABORATORY ANATOMIC & CLINICAL PATHOLOGY • PHYSICIAN BIOGRAPHIES Peter Millward, M.D. Mitual Amin, M.D. Chief of Clinical Pathology, Beaumont Health Interim Chair, Pathology and Laboratory Medicine, Interim Chief of Pathology Service Line, Beaumont Health Royal Oak Interim Physician Executive, Beaumont Medical Group Interim Chair, Department of Pathology and Laboratory Medicine, Oakland University William Beaumont School Interim System Medical Director, Beaumont Laboratory of Medicine Outreach Services Board certification Associate Medical Director, Blood Bank and • Anatomic and Clinical Pathology, Transfusion Medicine, Beaumont Health American Board of Pathology Board certification Additional fellowship training • Anatomic and Clinical Pathology, • Surgical Pathology American Board of Pathology Special interests Subspecialty board certification • Breast Pathology, Genitourinary Pathology, • Blood Banking and Transfusion Medicine, Gastrointestinal Pathology American Board of Pathology Lubna Alattia, M.D. Kurt D. Bernacki, M.D. Cytopathologist and Surgical Pathologist, Trenton System Medical Director, Surgical Pathology Board certification Beaumont Health • Anatomic and Clinical Pathology, Chief, Pathology Laboratory, West Bloomfield American Board of Pathology Breast Care Center Subspecialty board certification Diagnostic Lead, Pulmonary Tumor Pathology • Cytopathology, American Board of Pathology Diagnostic Lead, Surgical Pathology Additional fellowship training Assistant Professor, Department of Pathology • Surgical Pathology Interim Chief Anatomic Pathology and Laboratory Medicine, Oakland University Osama Alassi, M.D. William Beaumont School of Medicine Surgical Pathologist and Cytopathologist, Royal Oak Board certification Diagnostic Lead, Breast Pathology • Anatomic and Clinical Pathology, Program Director, Cytopathology Fellowship American Board of Pathology Assistant Professor, Department of Pathology Subspecialty board certification and Laboratory Medicine, Oakland University • Cytopathology, American Board of Pathology William Beaumont School of Medicine Additional fellowship training Board certification • Surgical Pathology • Anatomic and Clinical Pathology, American Board of Pathology Geetha Bhandarkar, M.D. Subspecialty board certification Cytopathologist, Dearborn • Cytopathology, American Board of Pathology Board certification Special interests • Anatomic and Clinical Pathology, • Breast Pathology, Thyroid and Endocrine Pathology American Board of Pathology Subspecialty board certification M. Jawwad Arshad, M.D. • Cytopathology, American Board of Pathology Chief, Anatomic Pathology, Trenton, Taylor, Wayne Hematopathologist, Dearborn Ann Marie Blenc, M.D. Medical Director, Canton Lab System Medical Director, Hematopathology Beaumont Health Board certification • Anatomic and Clinical Pathology, Diagnostic Lead, Hematopathology American Board of Pathology Course Director, School of Medical Subspecialty board certification Laboratory Science • Hematopathology, American Board of Pathology Associate Professor, Department of Pathology Additional fellowship training and Laboratory Medicine, Oakland University • Oncologic Surgical Pathology William Beaumont School of Medicine Special interests Board certification • Laboratory Management, Breast Pathology • Anatomic and Clinical Pathology, American Board of Pathology Subspecialty board certification • Hematopathology, American Board of Pathology 1 BEAUMONT LABORATORY ANATOMIC & CLINICAL PATHOLOGY • PHYSICIAN BIOGRAPHIES Leilei Chen, M.D. Vonda K. Douglas-Nikitin, M.D. Surgical Pathologist, Hematopathologist, Troy System Medical Director, Flow Cytometry, Associate Professor, Department of Pathology and Beaumont Health Laboratory Medicine, Oakland University William Program Director, Hematopathology Fellowship Beaumont School of Medicine Associate Professor, Department of Pathology Board certification and Laboratory Medicine, Oakland University • Anatomic and Clinical Pathology, William Beaumont School of Medicine American Board of Pathology Board certification Subspecialty board certification • Anatomic and Clinical Pathology, • Hematopathology, American Board of Pathology American Board of Pathology Subspecialty board certification Mark Chen, M.D. • Hematopathology, American Board of Pathology Surgical Pathologist, Trenton Board certification Jining Feng, M.D., Ph.D. • Anatomic and Clinical Pathology, System Medical Director, Cytopathology American Board of Pathology Diagnostic Lead, Cytology Additional fellowship training Diagnostic Lead, Genitourinary Pathology • Pediatric Pathology Associate Professor, Department of Pathology and Laboratory Medicine, Oakland University Xia Chen, M.D. William Beaumont School of Medicine Hematopathologist, Royal Oak Board certification Diagnostic Lead, Breast Pathology • Anatomic and Clinical Pathology, Board certification American Board of Pathology • Anatomic and Clinical Pathology, Subspecialty board certification American Board of Pathology • Cytopathology, American Board of Pathology Subspecialty board certification • Hematopathology, American Board of Pathology Thomas Fennell, M.D. Special interest Hematopathologist, Royal Oak • Breast Pathology Associate Residency Program Director Assistant Professor, Department of Pathology Nancy Corpuz, M.D. and Laboratory Medicine, Oakland University Cytopathologist, Troy William Beaumont School of Medicine Assistant Professor, Department of Pathology Board certification and Laboratory Medicine, Oakland University • Anatomic and Clinical Pathology, William Beaumont School of Medicine American Board of Pathology Board certification Subspecialty board certification • Anatomic and Clinical Pathology, • Hematopathology, American Board of Pathology American Board of Pathology Subspecialty board certification Craig Fletcher, M.D. • Cytopathology, American Board of Pathology System Medical Director, Blood Bank, Beaumont Health Medical Director, Blood Bank, Royal Oak, Susan Daraiseh, Ph.D. Farmington Hills Technical Director, Molecular Pathology, Beaumont Health, Royal Oak Assistant Professor, Department of Pathology and Laboratory Medicine, Oakland University Assistant Professor, Department of Pathology William Beaumont School of Medicine and Laboratory Medicine, Oakland University William Beaumont School of Medicine Board certification Special interest • Clinical Pathology, American Board of Pathology • Next Generation Sequencing, Bioinformatics Subspecialty board certification and Molecular Genomics • Blood Banking and Transfusion Medicine, American Board of Pathology 2 BEAUMONT LABORATORY ANATOMIC & CLINICAL PATHOLOGY • PHYSICIAN BIOGRAPHIES Joseph Fullmer, M.D., Ph.D. Christopher Hysell, M.D. Surgical Pathologist, Royal Oak Surgical Pathologist, Royal Oak System Medical Director, Autopsy, Medical Director, Immunohistochemistry Beaumont Health Diagnostic Lead, Soft Tissue, Bone Assistant Professor, Department of Pathology Associate Professor, Department of Pathology and Laboratory Medicine, Oakland University and Laboratory Medicine, Oakland University William Beaumont School of Medicine William Beaumont School of Medicine Board certification Board certification • Anatomic Pathology, American Board of Pathology • Anatomic and Clinical Pathology, Subspecialty board certification American Board of Pathology • Neuropathology, American Board of Pathology Subspecialty board certification • Cytopathology, American Board of Pathology Said Hafez-Khayyata, M.D. Special interest Cytopathologist, Dearborn • Soft Tissue and Bone Diagnostic Lead, Pulmonary and Thoracic Assistant Professor, Department of Pathology Kausar J. Jabbar, M.D. and Laboratory Medicine, Oakland University Surgical and Molecular Pathologist, Royal Oak William Beaumont School of Medicine Associate Medical Director, Molecular Pathology, Board certification Beaumont Health • Anatomic and Clinical Pathology, Assistant Professor, Department of Pathology American Board of Pathology and Laboratory Medicine, Oakland University Subspecialty board certification William Beaumont School of Medicine • Cytopathology, American Board of Pathology Board certification Special interest • Anatomic and Clinical Pathology, • Lung Pathology American Board of Pathology Subspecialty board certification Aparna Hariharan, M.D. • Hematopathology, American Board of Pathology Cytopathologist, Grosse Pointe • Molecular Genetic Pathology, American Board of Pathology Board certification • Anatomic and Clinical Pathology, Additional fellowship training American Board of Pathology • Cancer Bio Marker (Gastrointestinal Pathology) Subspecialty board certification • Cytopathology, American Board of Pathology Ryan Johnson, M.D. Associate Medical Director, Blood Bank • Hematopathology, American Board of Pathology Medical Director, Blood Bank, Troy and Grosse Pointe Associate System Medical Director, Blood Bank Sylvia Hayek, M.D. and Transfusion Medicine Cytopathologist, Dearborn Assistant Professor, Oakland University Board certification William Beaumont School of Medicine • Anatomic and Clinical Pathology, American Board of Pathology Board certification Subspecialty board certification • Anatomic and Clinical Pathology, • Cytopathology, American Board of Pathology American Board of Pathology Subspecialty board certification • Blood Banking and Transfusion Medicine, James Huang, M.D. American Board of Pathology Hematopathologist, Royal Oak
Load more

Recommended publications
  • Medical Directors Arup Medical Directors and Consulting Faculty | 2015
    MEDICAL DIRECTORS ARUP MEDICAL DIRECTORS AND CONSULTING FACULTY | 2015 MAY 2015 www.aruplab.com Information in this brochure is current as of May 2015. All content is subject to change. Please contact ARUP Client Services at (800) 522-2787 with any questions or concerns. ARUP LABORATORIES ARUP Laboratories is a national clinical and anatomic pathology reference laboratory and a nonprofit enterprise of the University of Utah and its Department of Pathology. Located in Salt Lake City, Utah, ARUP offers in excess of 3,000 tests and test combinations, ranging from routine screening tests to esoteric molecular and genetic assays. Rather than competing with its clients for physician office business, ARUP chooses instead to support clients’ existing test menus by offering complex and unique tests, with accompanying consultative support, to enhance their abilities to provide local and regional laboratory services. ARUP’s clients include many of the nation’s university teaching hospitals and children’s hospitals, as well as multihospital groups, major commercial laboratories, group purchasing organizations, military and other government facilities, and major clinics. In addition, ARUP is a worldwide leader in innovative laboratory research and development, led by the efforts of the ARUP Institute for Clinical and Experimental Pathology®. Since its formation in 1984 by the Department of Pathology at the University of Utah, ARUP has founded its reputation on reliable and consistent laboratory testing and service. This simple strategy contributes significantly to client satisfaction. When ARUP conducts surveys, clients regularly rate ARUP highly and respond that they would recommend ARUP to others. As the most responsive source of quality information and knowledge, ARUP strives to be the reference laboratory of choice for community healthcare systems.
    [Show full text]
  • Job Posting Clinical Microbiology Final
    The Department of Pathology & Cell Biology at Columbia University Irving Medical Center (CUIMC) is recruiting for an MD, MD/PhD, or PhD academic clinical microbiologist of any rank to join our faculty as a Medical Director of the NewYork-Presbyterian/CUIMC Clinical Microbiology Laboratory. Applicants should have an established track record of accomplishment within the field of clinical microbiology and a demonstrated ability to lead an experienced group of laboratory technologists, supervisors, and staff. In addition to strong clinical and technical skills, particular emphasis is placed on candidates with a demonstrated record of collegiality and inter-departmental collaboration. Applicants must have completed a fellowship in clinical microbiology and be board-certified/board-eligible in Medical and Public Health Microbiology through the American Board of Medical Microbiology (ABMM) or board-certified/board- eligible in Clinical Pathology with subspecialty certification in Medical Microbiology through the American Board of Pathology (ABP). The applicant must also be able to satify clinical licensing requirements to serve as a Laboratory Director in New York State. The successful applicant will help oversee diagnostic testing in the areas of Bacteriology, Virology, Mycobacteriology, Mycology, and Parasitology. The position also includes responsibilities for teaching of pathology residents, medical students, infectious diseases fellows, and technical staff. Applicants must be currently involved in ongoing research with a track record of publications in the field. The position offers a competitive salary commensurate with training and experience, and an appointment to the faculty of the Columbia University Vagelos College of Physicians & Surgeons. The Clinical Microbiology Laboratory at NewYork-Presbyterian/CUIMC is located in the Washington Heights neighborhood of New York City, offering unparalleled opportunities to work and live in a thriving, diverse, metropolitan environment with access to world-class cultural institutions, restaurants, and entertainment.
    [Show full text]
  • Hemepath 2021Rev3 EM Edits.Pub
    Hematopathology Faculty Emily F. Mason M.D., Ph.D. Hematopathology Fellowship Director; Assistant Professor of PMI *To apply, please submit application, 3 letters of recommendation, cover Kelley J. Mast, M.D. letter, and CV to: Hematopathology Associate Fellowship Director; Holly Spann, Administrative Assistant Assistant Professor of PMI Vanderbilt University School of Medicine Jonathan Douds, M.D. Department of Pathology, Microbiology Assistant Professor of PMI & Immunology David R. Head, M.D. Hematopathology Division Professor of PMI T3218 MCN Ridas Juskevicius, M.D. 1161 21st Avenue Assistant Professor of PMI Nashville, TN 37232 Claudio A. Mosse, M.D., Ph.D. [email protected] Associate Professor of PMI; Chief of Pathology and Lab Medicine, VA *Application and pertinent information Tennessee Valley Healthcare System can be found at: Adam C. Seegmiller, M.D., Ph.D. https://www.vumc.org/gme/13198 Professor of Pathology, Microbiology & Immunology (PMI); Vice Chair for Clinical Pathology; Vanderbilt Director of Laboratory Medicine and Hematopathology University Aaron C. Shaver, M.D., Ph.D. Associate Professor of PMI; Medical Center Director, Immunopathology Mary Ann Thompson Arildsen, M.D., Hematopathology Ph.D. Fellowship Associate Professor of PMI; Director, Hematology Hematopathology at (DMT). Through the hematologic malignancy DMT and in collaboration with clinical colleagues in con- project, the pathologist guides clinical decision- ferences and clinical-pathologic case analyses. Our Vanderbilt University Medical making and effective test utilization in diagnos- group provides service for the 670-bed Vanderbilt Center ing and treating hematologic University Hospital, the 216-bed Monroe Carell Jr. disorders. Children's Hospital, and the 282-bed VA Tennessee The Hematopathology We offer a one- or two- Valley Healthcare System, the site of the largest Division was started in year ACGME accredited fel- stem cell transplant program in the VA system.
    [Show full text]
  • Hematopathology Molecular Oncology Test Request
    Regional Pathology Services HEMATOPATHOLOGY University of Nebraska Medical Center Toll Free: 1.800.334.0459 981180 Nebraska Medical Center Phone: 402.559.6420 MOLECULAR ONCOLOGY Omaha, Nebraska 68198-1180 Fax: 402.559.9497 TEST REQUEST FORM www.reglab.org SHADED AREAS FOR PATIENT INFORMATION REQUIRED Accession #: _____________________________________ PATIENT LAST NAME FIRST NAME MI Date Rec’d: ____/____/____ # of Slides: _______________ DOB GENDER PT. ID# / ADDITIONAL INFO / MEDICAL RECORD NUMBER o MALE / / o AM FEMALE Collection Date ______/______/______ Collection Time ________ PM SSN BILL o OFFICE/CLIENT - - o PATIENT/PATIENT INSURANCE PHYSICIAN PROVIDER: _______________________________________ (Indicate the Supervising Dr./P.A. or N. Pract.) PATIENT INSURANCE ATTACH COPY OF FRONT AND BACK OF INSURANCE CARD AND ATTACH COPY OF FRONT OF DRIVERS LICENSE IF UNABLE TO OBTAIN COPY OF REQUIRED INFORMATION ALL FIELDS BELOW ARE REQUIRED PATHOLOGY CONSULTATION NUMBER GUARANTOR NAME/DOB (REQUIRED IF PATIENT IS A MINOR) ________________ Please provide direct phone number for pathology consultation if needed ADDRESS CITY STATE ZIP _______________ Account Number PRIMARY INSURANCE h MEDICARE IN-PATIENT h MEDICARE OUT-PATIENT h MEDICAID h INSURANCE ______________________________________________ Account Name POLICY ID# GROUP ID# ______________________________________________ INSURANCE COMPANY PHONE NUMBER Address ______________________________________________ INSURANCE COMPANY ADDRESS CITY STATE ZIP City, State & Zip Code Phone Number: __________________ EFFECTIVE DATE / / DIAGNOSIS / MEDICAL NECESSITY (ENTER ALL THAT APPLIES) Fax Number: __________________ SECONDARY / TERTIARY INS – ATTACH INFORMATION ICD-10 #1 ICD-10 #2 ICD-10 #3 NOTICE: WHEN ORDERING TESTS FOR WHICH MEDICARE REIMBURSEMENT WILL BE SOUGHT, PHYSICIANS SHOULD ONLY ORDER TESTS THAT ARE MEDICALLY NECESSARY FOR THE DIAGNOSIS OR TREATMENT OF A PATIENT RATHER THAN FOR h ABN ATTACHED h PRIOR AUTHORIZATION ATTACHED SCREENING PURPOSES.
    [Show full text]
  • Geriatric Medicine and Why We Need Geriatricians! by Juergen H
    Geriatric Medicine and why we need Geriatricians! by Juergen H. A. Bludau, MD hat is geriatric medicine? Why is there a need for 1. Heterogeneity: As people age, they become more Wthis specialty? How does it differ from general heterogeneous, meaning that they become more and more internal medicine? What do geriatricians do differently when different, sometimes strikingly so, with respect to their they evaluate and treat an older adult? These are common health and medical needs. Imagine for a moment a group questions among patients and physicians alike. Many of 10 men and women, all 40 years old. It is probably safe internists and family practitioners argue, not unjustifiably, to say that most, if not all, have no chronic diseases, do not that they have experience in treating and caring for older see their physicians on a regular basis, and take no long- patients, especially since older adults make up almost half of term prescription medications. From a medical point of all doctors visits. So do we really need another type of view, this means that they are all very similar. Compare this physician to care for older adults? It is true that geriatricians to a group of 10 patients who are 80 years old. Most likely, may not necessarily treat older patients differently per se. But you will find an amazingly fit and active gentleman who there is a very large and important difference in that the focus may not be taking any prescription medications. On the of the treatment is different. In order to appreciate how other end of the spectrum, you may find a frail, memory- significant this is, we need to look at what makes an older impaired, and wheelchair-bound woman who lives in a adult different from a younger patient.
    [Show full text]
  • DUKE UNIVERSITY School of Medicine Pathologists' Assistant
    DUKE UNIVERSITY School of Medicine Pathologists’ Assistant Program Department of Pathology Academic Programs The Department of Pathology at Duke University offers a wide array of training programs to fit individual requirements and goals. The Residency Training program is an ACGME approved program and is available as an Anatomic Pathology/Clinical Pathology combined program, a shorter Anatomic Pathology only program, or an Anatomic Pathology/Neuropathology program. Subspecialty fellowships in Cytopathology, Dermatopathology, Hematopathology, Medical Microbiology, and Neuropathology are also ACGME approved. These programs provide the highest quality of graduate medical education by drawing on the depth and breadth of faculty expertise in the Department in all aspects of anatomic and clinical pathology and the availability of a wide variety of often complex clinical cases seen at Duke University Health System. For medical students interested in a career in Pathology pre-doctoral fellowships, internships and externships are available. Research Training in Experimental pathology can be obtained through Pre- and postdoctoral fellowships of one to five years. All pre-doctoral fellows are candidates for the Ph.D. degree in pathology. The Ph.D. is optional in postdoctoral programs, which provide didactic and research training in various aspects of modern experimental pathology. A two year NAACLS accredited Pathologists’ Assistant Program leads to a Master of Health Science degree, certifies graduates to sit for the ASCP Board of Certification examination, and leads to exciting career opportunities in a variety of anatomic pathology laboratory settings. Pathologists’ assistants are analogous to physician assistants, but with highly specialized training in autopsy and surgical pathology. This profession was pioneered in the Duke Department of Pathology 50 years ago, and is one of only twelve such programs in existence today.
    [Show full text]
  • Understanding Your Pathology Report: Benign Breast Conditions
    cancer.org | 1.800.227.2345 Understanding Your Pathology Report: Benign Breast Conditions When your breast was biopsied, the samples taken were studied under the microscope by a specialized doctor with many years of training called a pathologist. The pathologist sends your doctor a report that gives a diagnosis for each sample taken. Information in this report will be used to help manage your care. The questions and answers that follow are meant to help you understand medical language you might find in the pathology report from a breast biopsy1, such as a needle biopsy or an excision biopsy. In a needle biopsy, a hollow needle is used to remove a sample of an abnormal area. An excision biopsy removes the entire abnormal area, often with some of the surrounding normal tissue. An excision biopsy is much like a type of breast-conserving surgery2 called a lumpectomy. What does it mean if my report uses any of the following terms: adenosis, sclerosing adenosis, apocrine metaplasia, cysts, columnar cell change, columnar cell hyperplasia, collagenous spherulosis, duct ectasia, columnar alteration with prominent apical snouts and secretions (CAPSS), papillomatosis, or fibrocystic changes? All of these are terms that describe benign (non-cancerous) changes that the pathologist might see under the microscope. They do not need to be treated. They are of no concern when found along with cancer. More information about many of these can be found in Non-Cancerous Breast Conditions3. What does it mean if my report says fat necrosis? Fat necrosis is a benign condition that is not linked to cancer risk.
    [Show full text]
  • Clinical Microbiology Core Rotation
    C:\Documents and Settings\jdnoll\Desktop\UofFCytolRot10.doc CYTOPATHOLOGY ROTATION Site: University of Florida-Gainesville/ Shands North & South Tower Faculty: Peter Drew, M.D. (4-4969) Larry J. Fowler, M.D., Cytology Director (4-4959) Jacquelyn Knapik, M.D. (4-3887) Li Lu, M.D, PhD (63-6440) Demaretta Rush, M.D. (5-3364) Edward Wilkinson, M.D. (4-4962) Anthony Yachnis, M.D., Anatomic Pathology Director (4-4951) Current Cytopathology Fellow Charlene M. Lewis, CT (ASCP) Superviser Deborah A. Carroll, CT, (ASCP) Patricia Christensen, CT (ASCP) David A. Lemire, CT (ASCP) Rotation Periods: 12 weeks for CORE Rotation broken into three 4 week rotations (a portion of the 12 weeks may be on the VA Hospital Cytology Rotation). Offered all 12 months of any training year. I. General Organization: The cytopathology core rotation consists of three 4 week rotations (total 12 weeks) routinely placed within the 1st thru 4th PGY training years of a 4 year APCP training program. The CORE rotation may also be done in one combined 12 week rotation upon special request. Cervical biopsies and local gynecologic excisions are signed out in tandem with cytology specimens (correlation of surgical and cytologic specimens). The first 4 week's rotation, residents review the day's cases at the time of sign-out with the faculty member on service. During the second and third 4 week rotations residents preview cases before sign-out, render preliminary interpretations, and receive feedback at sign out (graduated responsibility). Fellows preview the slides before sign-out and render interpretations, and have the option to attend sign-out or receive feedback from the attending pathologist later (graduated responsibility).
    [Show full text]
  • A Crisis in Health Care: a Call to Action on Physician Burnout
    A CRISIS IN HEALTH CARE: A CALL TO ACTION ON PHYSICIAN BURNOUT Partnership with the Massachusetts Medical Society, Massachusetts Health and Hospital Association, Harvard T.H. Chan School of Public Health, and Harvard Global Health Institute A Crisis in Health Care: A Call to Action on Physician Burnout Authors About the Massachusetts Medical Society Ashish K. Jha, MD, MPH The Massachusetts Medical Society (MMS) is the state- Director, Harvard Global Health Institute wide professional association for physicians and medical stu- Senior Associate Dean for Research Translation and dents, supporting 25,000 members. The MMS is dedicated Global Strategy to educating and advocating for the physicians and patients K.T. Li Professor, Dept. of Health Policy and Management, of Massachusetts both locally and nationally. As a voice of Harvard T.H. Chan School of Public Health leadership in health care, the MMS provides physician and Professor of Medicine, Harvard Medical School patient perspectives to influence health-related legislation Andrew R. Iliff, MA, JD at both state and federal levels, works in support of public Lead Writer and Program Manager, Harvard Global health, provides expert advice on physician practice manage- Health Institute ment, and addresses issues of physician well-being. Alain A. Chaoui, MD, FAAFP About the Massachusetts Health and President, Massachusetts Medical Society Hospital Association Steven Defossez, MD, EMHL The Massachusetts Health and Hospital Association Vice President, Clinical Integration, Massachusetts Health (MHA) was founded in 1936, and its members include and Hospital Association 71 licensed member hospitals, many of which are organized Maryanne C. Bombaugh, MD, MSc, MBA within 29 member health systems, as well as interested indi- President-Elect, Massachusetts Medical Society viduals and other healthcare stakeholders.
    [Show full text]
  • Cytopathology Fellowship Faculty of Medicine, Postgraduate Medical Education
    Cytopathology Fellowship Faculty of Medicine, Postgraduate Medical Education Institution: McGill University and McGill University Health Centre Location: Department of Pathology, MUHC and Duff Medical Building Type of Fellowship: One year clinical fellowship in Cytopathology Fellowship Program Director: Dr. Manon Auger Program Information Number of fellowship positions requested: One Academic affiliation: McGill University Name of hospitals involved in training: McGill University Health Centre (MUHC) Background: The fellowship will be principally based at the MUHC. This one-year post-residency clinical fellowship offers a comprehensive, integrated exposure to the field of Cytopathology. The cytological specimens handled at the MUHC include approximately 50,000 gynecological specimens per year (including approximately 7000 colposcopic specimens) as well as 10,000 non-gynecological specimens (including approximately 4000 fine needle aspirates). Exposure to liquid- based cytology is provided. Research activity and publications: The fellow will be expected to participate in at least one major research project involving, at minimum, a review of a series of cases (i.e., not simply a case report) with a view to publication in a peer-reviewed journal (i.e. not only presentation at a meeting). In addition, other research projects may be carried out, including case reports. Mission and objectives: The general mission of the fellowship is to provide training in the interpretation of cytopathology with a view to learn the entire spectrum of reactive
    [Show full text]
  • Simple Technique to Identify Haemosiderin in Immunoperoxidase Stained Sections
    J Clin Pathol: first published as 10.1136/jcp.37.10.1190 on 1 October 1984. Downloaded from 1190 Technical methods Phosphate buffer at pH 8*0 gave the sharpest 2 Rozenszajn L, Leibovich M, Shoham D, Epstein J. The esterase staining reactions, although there was little differ- activity in megaloblasts, leukaemic and normal haemopoietic cells. Br J Haematol 1968; 14:605-19. ence at pH 7-0 or pH 7-5. As the buffer pH was 3Hayhoe FGJ, Quaglino D. Haematological cytochemistry. Edin- increased above pH 8-0 staining with both substrates burgh: Churchill Livingstone, 1980. became progressively weaker, especially above pH 4Li CY, Lam KW, Yam LT. Esterases in human leucocytes. J 9.0. Below pH 7-0 staining with a-naphthyl butyrate Histochem Cytochem 1973;21:1-12. Yam LT, Li CY, Crosby WH. Cytochemical identification of became weaker, and below pH 5*0 staining with monocytes and granulocytes. Am J Clin Pathol 1971;55:283- naphthol AS-D chloroacetate began to disappear. 90. 6 Armitage RJ, Linch DC, Worman CP, Cawley JC. The morphol- This work was supported by a Medical Research ogy and cytochemistry of human T-cell subpopulations defined by monoclonal antibodies and Fc receptors. Br J Haematol Council project grant. I thank Professor FGJ 1983;51:605-13. Hayhoe for valuable advice. References Requests for reprints to: Dr DM Swirsky, Department of Gomori G. Chloroacyl esters as histochemical substrates. J His- Haematological Medicine, University Clinical School, Hills tochem Cytochem 1953;1:469-70. Road, Cambridge CB2 2QL, England. Simple technique to identify identification of the two compounds on the same haemosiderin in slide.
    [Show full text]
  • Medical Microbiology and Infectious Diseases 22% Specialists in 2017 = 11%3
    Medical Microbiology & Infectious Diseases Profile Updated December 2019 1 Table of Contents Slide . General Information 3-5 . Total number & number/100,000 population by province, 2019 6 . Number/100,000 population, 1995-2019 7 . Number by gender & year, 1995-2019 8 . Percentage by gender & age, 2019 9 . Number by gender & age, 2019 10 . Percentage by main work setting, 2019 11 . Percentage by practice organization, 2017 12 . Hours worked per week (excluding on-call), 2019 13 . On-call duty hours per month, 2019 14 . Percentage by remuneration method 15 . Professional & work-life balance satisfaction, 2019 16 . Number of retirees during the three year period of 2016-2018 17 . Employment situation, 2017 18 . Links to additional resources 19 2 General information Microbiology and infectious diseases focuses on the diagnosis and treatment of infectious diseases; thus, it is concerned with human illness due to micro-organisms. Since such disease can affect any and all organs and systems, this specialist must be prepared to deal with any region of the body. The specialty of Medical Microbiology and Infectious Disease consists primarily of four major spheres of activity: 1. the provision of clinical consultations on the investigation, diagnosis and treatment of patients suffering from infectious diseases; 2. the establishment and direction of infection control programs across the continuum of care; 3. public health and communicable disease prevention and epidemiology; 4. the scientific and administrative direction of a diagnostic microbiology laboratory. Source: Pathway evaluation program 3 General information Once you’ve completed medical school, it takes an additional 5 years of Royal College-approved residency training to become certified in medical microbiology and infectious disease.
    [Show full text]